FBXO32 and cancer: In previous studies, atrogin-1/MAFbx was reportedly increased 8–40-fold in muscle atrophy due to renal failure, cancer, and diabetes, and a 3-fold increase in muscle atrophy was induced by immobilization, denervation, and hindlimb suspension [9].